The sun still hasn't set on gene patents
Last week saw the conclusion of the long-running gene patent lawsuit known as AMP v. Myriad Genetics. At stake was the patentability of isolated DNA sequences...
A patent on a specific gene sequence, its chemical composition, and/or processes for obtaining or using it.
by Dr Michael Hopkins and 1 others
Last week saw the conclusion of the long-running gene patent lawsuit known as AMP v. Myriad Genetics. At stake was the patentability of isolated DNA sequences...
by Dr Jane Kaye
The US Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics will have far-reaching implications, not just by lowering the costs of genetic tests, but also for the development of innovations in genetics and genomics and in other emerging fields such as stem cell research and synthetic biology....
The US Supreme Court has unanimously rejected a number of patent claims made by Myriad Genetics on isolated forms of two genes, BRCA1 and BRCA2, associated with an increased risk of breast and ovarian cancer....
by BioNews
A patent over a method for assessing cell-cycle data that can be used in IVF treatments to predict an embryo's future viability will make IVF treatments in the USA prohibitively expensive, a leading embryologist has said...
A new study has reported that the entire human genome may be under patents held by commercial companies....
Patents on human genes continue to cause controversy in the academic and popular press. A recent decision in Australia has reaffirmed the patentability of isolated human DNA in that jurisdiction...
A patent over a gene linked to hereditary breast and ovarian cancers is valid, an Australian federal court has ruled in a landmark case....
The controversial issues discussed in BioNews aren't all black and white - fifty shades of grey is perhaps a more accurate description...
A group of academics has accused Myriad Genetics, the US biotech company that holds patents over the BRCA1 and BRCA2 genetic tests for increased risk of breast cancer, of keeping secret clinical data obtained from the tests by saying the information is commercially sensitive...
The American Civil Liberties Union has asked the US Supreme Court to reconsider its decision to uphold the patent held by Myriad Genetics on two human genes associated with hereditary breast and ovarian cancers...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.